Trending Topic

23 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked
Luke G Qin, Michael T Pierce, Rachel C Robbins

The uvea is a vascular stratum that includes the iris, ciliary body and choroid. Uveitis is defined as inflammation of a part of the uvea or its entirety, but it is also used to describe inflammatory processes of any part of the eye, such as the vitreous or peripheral retina. The clinical taxonomy of uveitis […]

Dinah Zur, EURETINA 2022: Type 1 Neovascularization or Central Serous Chorioretinopathy?

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Published Online: Sep 13th 2022

Type 1 neovascularization can be a secondary feature of central serous chorioretinopathy. In this touchOPHTHALMOLOGY interview, Dr Dinah Zur (Center for Retinal Degenerations, Ophthalmology Division, Tel-Aviv Sourasky Medical Center, Tel-Aviv, Israel) talks us through the implications of improper diagnosis of this condition for optimal management and the imaging techniques that are recommended for diagnosis.

Questions:

  1. What are the clinical features of type 1 neovascularization in patients who do not have age-related macular degeneration but instead have features consistent with central serous chorioretinopathy? (00:19)
  2. What are the implications of improper diagnosis of this condition for optimal management? (01:07)
  3. What imaging techniques are recommended for diagnosis? (01:51)
  4. What are the key take home messages of your presentation? (03:55)

The abstract ‘Type 1 neovascularisation or CSC?’ was presented at EURETINA 2022, 1–4 September 2022

Disclosure: Dinah Zur has nothing to disclose in relation to this video.

Support: Interview and filming supported by Touch Medical Media Ltd. Interview conducted by Lisa Glass.

Filmed as a highlight of EURETINA 2022.

Share
Facebook
X (formerly Twitter)
LinkedIn
Via Email
Mark CompleteCompleted
BookmarkBookmarked
Copy LinkLink Copied
Close Popup